[PERSON]
Yi-Long Wu
Featured in 1 tracked story · first seen
Situations
Osimertinib efficacy and evolving NSCLC treatment trends
4 clusters · 18 sources · last updated
Latest: Italy advances cancer prevention and oncology treatments
Updated data from the Phase III ADAURA study, presented at the World Conference on Lung Cancer in Seoul, indicates that osimertinib provides sustained and clinically significant overall survival benefits for patients wit